Precision NanoSystems Announces New Cell Therapy Reagent for Lipid Nanoparticle -based mRNA Delivery to T Cells

"The COVID-19 mRNA-LNP vaccines have demonstrated the power of lipid nanoparticle technology for the rapid development of highly effective genetic medicines" said Dr. James Taylor, CEO & cofounder of PNI.  "PNI believes that LNP technology can also accelerate the development of transformative cell therapies and we are thrilled to launch a LNP reagent kit specifically designed for the efficient delivery of mRNA into T cells using PNI's proprietary GenVoy-ILM™ delivery platform." "The COVID-19...

VANCOUVER, BC, 20/04/2021 (informazione.news - comunicati stampa - scienza e tecnologia)

"The COVID-19 mRNA-LNP vaccines have demonstrated the power of lipid nanoparticle technology for the rapid development of highly effective genetic medicines" said Dr. James Taylor , CEO & cofounder of PNI.  "PNI believes that LNP technology can also accelerate the development of transformative cell therapies and we are thrilled to launch a LNP reagent kit specifically designed for the efficient delivery of mRNA into T cells using PNI's proprietary GenVoy-ILM™ delivery platform."

Dr. Angelo Cardoso , Director of the Laboratory for Cellular Medicine at the Beckman Research Institute at City of Hope, also expressed excitement about PNI's launch of GenVoy-ILM T Cell Kit for mRNA, "LNP designed for defined cell types open new opportunities for the manufacture of gene-edited cell therapies and, hopefully in the future, gene targeting."

Learn more about the GenVoy-ILM T Cell Kit for mRNA by registering for our upcoming webinars on May 6  and May 11 . And Join us at the American Society of Gene & Cell Therapy Annual Meeting for a PNI sponsored symposium "Accelerating Genetic Medicine Development with Lipid Nanoparticles" at 2-3:30 PM ET on May 13 , 2021.

Learn more about those events at https://www.precisionnanosystems.com/resources-and-community/learningpaths/events.

Learn more about Precision NanoSystems and the GenVoy-ILM T Cell Kit for mRNA at https://www.precisionnanosystems.com.

PNI is a global leader ushering in the next wave of genetic medicines in infectious diseases, cancer and rare diseases. We work with the world's leading drug researchers to understand disease and create the therapeutics and vaccines that will define the future of medicine. PNI offers proprietary technology platforms and comprehensive expertise to enable researchers to translate disease biology insights into non-viral genetic medicines.

Helena Rebec, Precision NanoSystems, Email: media@precision-nano.com, Phone: 1-888-618-0031 Ext. 222